Viva Biotech Holdings (FRA:VB0)
Germany · Delayed Price · Currency is EUR 0.1860
-0.0050 (-2.62%)
Last updated: Jan 2, 2026, 8:07 AM CET
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of €451.5 million as of January 9, 2026. Its market cap has increased by 98.22% in one year.
Market Cap
451.50M
Enterprise Value
483.70M
Revenue
218.31M
Ranking
n/a
PE Ratio
22.05
Stock Price
€0.19
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 752.12M to 451.50M, a decrease of -39.97%. That is a compound annual growth rate of -7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 451.50M | 8.63% |
| Dec 31, 2025 | 415.65M | 83.93% |
| Dec 31, 2024 | 225.99M | -13.23% |
| Dec 29, 2023 | 260.44M | -35.25% |
| Dec 30, 2022 | 402.25M | -60.56% |
| Dec 31, 2021 | 1.02B | -44.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |